Led · Series A · Mar 2026

eMed operates an employer-focused population health platform built around an empathic agentic AI system and clinically managed GLP-1 programs. The company says its GLP-1 program achieves more than 90% member adherence—over double the industry norm—and reports an average weight loss of 21 pounds, with 99% of participants improving at least one key biomarker within six months. eMed highlights strong demand for workplace GLP-1 benefits, noting only one in five companies currently provide them. The company plans to use the new capital to further develop its AI platform and to support a capitated model designed to help employers reduce healthcare costs. eMed is led by CEO Linda Yaccarino and lists Tom Brady as its Founding Chief Wellness Officer and investor.

Participated · Debt Financing · May 2023

Embr Labs makes the Embr Wave® wristband, a patented wearable that delivers precisely calibrated cooling or warming sensations to provide instant, discreet control over hot flashes and related menopause symptoms. Led by CEO Elizabeth Gazda and based in Boston, MA, the company markets the device through major retail and distribution partners. Embr Wave is available at Costco, Sam’s Club, Walmart, FSA Store and HSA Store, BestBuy, and Target, and the company plans to launch in additional retailers in the US and UK by year-end. The company raised $35m in an intellectual property‑based debt financing to support its consumer growth strategy. Embr intends to use the funds to accelerate retail and geographic expansion. The round was led by GT Investment Partners in collaboration with Aon plc. Embr Labs makes the Wave bracelet, a wearable that delivers algorithmically-designed, patented thermal waveforms to cool or warm temperature-sensitive nerves. Founded by three engineers in a cold lab at MIT and led by CEO Elizabeth Gazda, the company launched the Wave in September 2017 and has sold tens of thousands of devices since. Embr plans to grow its presence in wellness and digital therapeutics, accelerate development of the next generation of its core technology platform, and validate new use cases in thermal wellness. The company is based in Cambridge, MA. Financially, Embr raised $6M in a Series B to support those efforts.

Led · Debt Financing · Apr 2022

CHASM Advanced Materials is a Massachusetts-based company working in advanced materials. The company recently finalized a $25 million intellectual property-based funding arrangement with Aon. Aon's IP Solutions team combined proprietary IP valuation tools and a collateral protection insurance policy to create an IP-collateralized debt structure for CHASM. That structure enabled CHASM to raise additional funds by leveraging its intangible assets. Aon says it is working with IP-rich companies like CHASM to help them seek access to minimally dilutive growth capital. Aon was also recently named to Fast Company's Most Innovative Companies list and is promoting such IP-based capital solutions. Chasm Advanced Materials invents and manufactures nanotube hybrids, a new class of advanced materials used to improve device technology, transportation, infrastructure, healthcare and natural resources. Its commercial product lines include AgeNT™ for transparent flexible printed electronics, NTeC™ for energy storage, coatings and composite additives, and Signis™ for touch buttons and sensors with superior environmental stability. The company plans to launch CHASM-H2O™ — a new category of membranes targeted at disrupting water treatment to address global water scarcity. Led by CEO David Arthur, Chasm supplies global manufacturers across multiple industries that have brought first-to-market products using its materials. In August 2021 the company closed a $15M Series C to support commercial penetration of its product lines and the CHASM-H2O™ launch.